A case has been described as a carrier of the TARDBP K263E mutation who developed FTD, progressive supranuclear palsy (PSP), and chorea; furthermore, these symptoms were correlated with the presence of TDP-43 inclusions in the brainstem and subcortical nuclei, both in neurons and glia. Here, TARDBP is linked to progressive supranuclear palsy.